Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity

Immunity

Volumn 40, Issue 6, 2014, Pages 949-960

  Xu, Haifeng C ^a,b   Grusdat, Melanie ^a   Pandyra, Aleksandra A ^b   Polz, Robin ^a   Huang, Jun ^a   Sharma, Piyush ^b   Deenen, René ^a   Köhrer, Karl ^a   Rahbar, Ramtin ^c   Diefenbach, Andreas ^d   Gibbert, Kathrin ^e   Löhning, Max ^f,g   Höcker, Lena ^h   Waibler, Zoe ^h   Häussinger, Dieter ^a   Mak, Tak W ^c   Ohashi, Pamela S ^c   Lang, Karl S ^b   Lang, Philipp A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^h PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; PERFORIN;

ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXICITY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICROARRAY ANALYSIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; IMMUNITY, INNATE; INTERFERON TYPE I; KILLER CELLS, NATURAL; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PERFORIN; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 84902651736     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.05.004     Document Type: Article

References (60)

1. Agarwal P., Raghavan A., Nandiwada S.L., Curtsinger J.M., Bohjanen P.R., Mueller D.L., Mescher M.F. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 Tcell effector function and memory. J.Immunol. 2009, 183:1695-1704.
2. Ahlenstiel G., Titerence R.H., Koh C., Edlich B., Feld J.J., Rotman Y., Ghany M.G., Hoofnagle J.H., Liang T.J., Heller T., Rehermann B. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 2010, 138:325-335. e321-322.
3. Ahlenstiel G., Edlich B., Hogdal L.J., Rotman Y., Noureddin M., Feld J.J., Holz L.E., Titerence R.H., Liang T.J., Rehermann B. Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology 2011, 141:1231-1239. e1231-e1232.
4. Aichele P., Unsoeld H., Koschella M., Schweier O., Kalinke U., Vucikuja S. CD8 Tcells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J.Immunol. 2006, 176:4525-4529.
5. Andrews D.M., Estcourt M.J., Andoniou C.E., Wikstrom M.E., Khong A., Voigt V., Fleming P., Tabarias H., Hill G.R., van der Most R.G., et al. Innate immunity defines the capacity of antiviral Tcells to limit persistent infection. J.Exp. Med. 2010, 207:1333-1343.
6. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 Tcells during chronic viral infection. Nature 2006, 439:682-687.
7. Biron C.A., Nguyen K.B., Pien G.C. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 2002, 263:7-27.
8. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
9. Cook K.D., Whitmire J.K. The depletion of NK cells prevents Tcell exhaustion to efficiently control disseminating virus infection. J.Immunol. 2013, 190:641-649.
10. Crouse J., Bedenikovic G., Wiesel M., Ibberson M., Xenarios I., Von Laer D., Kalinke U., Vivier E., Jonjic S., Oxenius A. Type I Interferons Protect T Cells against NK Cell Attack Mediated by the Activating Receptor NCR1. Immunity 2014, 40. Published online June 5, 2014. 10.1016/j.immuni.2014.05.003.
11. Edlich B., Ahlenstiel G., Zabaleta Azpiroz A., Stoltzfus J., Noureddin M., Serti E., Feld J.J., Liang T.J., Rotman Y., Rehermann B. Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology 2012, 55:39-48.
12. Gascoyne D.M., Long E., Veiga-Fernandes H., de Boer J., Williams O., Seddon B., Coles M., Kioussis D., Brady H.J. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 2009, 10:1118-1124.
13. Gautier G., Humbert M., Deauvieau F., Scuiller M., Hiscott J., Bates E.E., Trinchieri G., Caux C., Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J.Exp. Med. 2005, 201:1435-1446.
14. Gilliet M., Cao W., Liu Y.J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 2008, 8:594-606.
15. González-Navajas J.M., Lee J., David M., Raz E. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 2012, 12:125-135.
16. Gründemann C., Schwartzkopff S., Koschella M., Schweier O., Peters C., Voehringer D., Pircher H. The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function invivo. Eur. J. Immunol. 2010, 40:1303-1314.
17. He X.S., Ji X., Hale M.B., Cheung R., Ahmed A., Guo Y., Nolan G.P., Pfeffer L.M., Wright T.L., Risch N., et al. Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology 2006, 44:352-359.
18. Huang W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37:1-13.
19. Huang W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
20. Jin H.T., Anderson A.C., Tan W.G., West E.E., Ha S.J., Araki K., Freeman G.J., Kuchroo V.K., Ahmed R. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 2010, 107:14733-14738.
21. Jones R.B., Ndhlovu L.C., Barbour J.D., Sheth P.M., Jha A.R., Long B.R., Wong J.C., Satkunarajah M., Schweneker M., Chapman J.M., et al. Tim-3 expression defines a novel population of dysfunctional Tcells with highly elevated frequencies in progressive HIV-1 infection. J.Exp. Med. 2008, 205:2763-2779.
22. Kaech S.M., Cui W. Transcriptional control of effector and memory CD8+ Tcell differentiation. Nat. Rev. Immunol. 2012, 12:749-761.
23. Kaech S.M., Tan J.T., Wherry E.J., Konieczny B.T., Surh C.D., Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 Tcells that give rise to long-lived memory cells. Nat. Immunol. 2003, 4:1191-1198.
24. Kägi D., Ledermann B., Bürki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., Hengartner H. Cytotoxicity mediated by Tcells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 1994, 369:31-37.
25. Kamizono S., Duncan G.S., Seidel M.G., Morimoto A., Hamada K., Grosveld G., Akashi K., Lind E.F., Haight J.P., Ohashi P.S., et al. Nfil3/E4bp4 is required for the development and maturation of NK cells invivo. J.Exp. Med. 2009, 206:2977-2986.
26. Kamphuis E., Junt T., Waibler Z., Forster R., Kalinke U. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood 2006, 108:3253-3261.
27. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., Cheng J., Goedert J.J., Vlahov D., Hilgartner M., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004, 305:872-874.
28. Knapp S., Warshow U., Hegazy D., Brackenbury L., Guha I.N., Fowell A., Little A.M., Alexander G.J., Rosenberg W.M., Cramp M.E., Khakoo S.I. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus. Hepatology 2010, 51:1168-1175.
29. Koller B.H., Marrack P., Kappler J.W., Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ Tcells. Science 1990, 248:1227-1230.
30. Kolumam G.A., Thomas S., Thompson L.J., Sprent J., Murali-Krishna K. Type I interferons act directly on CD8 Tcells to allow clonal expansion and memory formation in response to viral infection. J.Exp. Med. 2005, 202:637-650.
31. Koo G.C., Peppard J.R. Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma 1984, 3:301-303.
32. Lang P.A., Recher M., Honke N., Scheu S., Borkens S., Gailus N., Krings C., Meryk A., Kulawik A., Cervantes-Barragan L., et al. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 2010, 52:25-32.
33. Lang P.A., Lang K.S., Xu H.C., Grusdat M., Parish I.A., Recher M., Elford A.R., Dhanji S., Shaabani N., Tran C.W., et al. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl. Acad. Sci. USA 2012, 109:1210-1215.
34. Lang P.A., Xu H.C., Grusdat M., McIlwain D.R., Pandyra A.A., Harris I.S., Shaabani N., Honke N., Maney S.K., Lang E., et al. Reactive oxygen species delay control of lymphocytic choriomeningitis virus. Cell Death Differ. 2013, 20:649-658.
35. Lau D.T., Negash A., Chen J., Crochet N., Sinha M., Zhang Y., Guedj J., Holder S., Saito T., Lemon S.M., et al. Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection. Gastroenterology 2013, 144:402-413. e412.
36. Le Bon A., Durand V., Kamphuis E., Thompson C., Bulfone-Paus S., Rossmann C., Kalinke U., Tough D.F. Direct stimulation of Tcells by type I IFN enhances the CD8+ Tcell response during cross-priming. J.Immunol. 2006, 176:4682-4689.
37. Lee S.H., Kim K.S., Fodil-Cornu N., Vidal S.M., Biron C.A. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 Tcell regulation during viral infection. J.Exp. Med. 2009, 206:2235-2251.
38. Marshall H.D., Prince A.L., Berg L.J., Welsh R.M. IFN-alpha beta and self-MHC divert CD8 Tcells into a distinct differentiation pathway characterized by rapid acquisition of effector functions. J.Immunol. 2010, 185:1419-1428.
39. Müller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
40. Nguyen K.B., Watford W.T., Salomon R., Hofmann S.R., Pien G.C., Morinobu A., Gadina M., O'Shea J.J., Biron C.A. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 2002, 297:2063-2066.
41. Oliviero B., Varchetta S., Paudice E., Michelone G., Zaramella M., Mavilio D., De Filippi F., Bruno S., Mondelli M.U. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009, 137:1151-1160. e1151-e1157.
42. Oliviero B., Mele D., Degasperi E., Aghemo A., Cremonesi E., Rumi M.G., Tinelli C., Varchetta S., Mantovani S., Colombo M., Mondelli M.U. Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection. J.Hepatol. 2013, 59:38-44.
43. Oxenius A., Bachmann M.F., Zinkernagel R.M., Hengartner H. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 1998, 28:390-400.
44. Paladino N., Flores A.C., Marcos C.Y., Fainboim H., Theiler G., Arruvito L., Williams F., Middleton D., Fainboim L. Increased frequencies of activating natural killer receptors are associated with liver injury in individuals who do not eliminate hepatitis C virus. Tissue Antigens 2007, 69(Suppl 1):109-111.
45. Petricoin E.F., Ito S., Williams B.L., Audet S., Stancato L.F., Gamero A., Clouse K., Grimley P., Weiss A., Beeler J., et al. Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. Nature 1997, 390:629-632.
46. Pircher H., Bürki K., Lang R., Hengartner H., Zinkernagel R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989, 342:559-561.
47. Rabinovich B.A., Li J., Shannon J., Hurren R., Chalupny J., Cosman D., Miller R.G. Activated, but not resting, Tcells can be recognized and killed by syngeneic NK cells. J.Immunol. 2003, 170:3572-3576.
48. Rehermann B. Pathogenesis of chronic viral hepatitis: differential roles of Tcells and NK cells. Nat. Med. 2013, 19:859-868.
49. Rehermann B., Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 2005, 5:215-229.
50. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008, 8:559-568.
51. Santini S.M., Lapenta C., Logozzi M., Parlato S., Spada M., Di Pucchio T., Belardelli F. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity invitro and in Hu-PBL-SCID mice. J.Exp. Med. 2000, 191:1777-1788.
52. Sarasin-Filipowicz M., Oakeley E.J., Duong F.H., Christen V., Terracciano L., Filipowicz W., Heim M.H. Interferon signaling and treatment outcome in chronic hepatitis C. Proc. Natl. Acad. Sci. USA 2008, 105:7034-7039.
53. Su H.C., Nguyen K.B., Salazar-Mather T.P., Ruzek M.C., Dalod M.Y., Biron C.A. NK cell functions restrain Tcell responses during viral infections. Eur. J. Immunol. 2001, 31:3048-3055.
54. Takahashi K., Asabe S., Wieland S., Garaigorta U., Gastaminza P., Isogawa M., Chisari F.V. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc. Natl. Acad. Sci. USA 2010, 107:7431-7436.
55. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
56. Vivier E., Raulet D.H., Moretta A., Caligiuri M.A., Zitvogel L., Lanier L.L., Yokoyama W.M., Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science 2011, 331:44-49.
57. Waggoner S.N., Taniguchi R.T., Mathew P.A., Kumar V., Welsh R.M. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ Tcells, leading to prolonged viral persistence and altered pathogenesis. J.Clin. Invest. 2010, 120:1925-1938.
58. Waggoner S.N., Cornberg M., Selin L.K., Welsh R.M. Natural killer cells act as rheostats modulating antiviral Tcells. Nature 2012, 481:394-398.
59. Waggoner S.N., Daniels K.A., Welsh R.M. Therapeutic depletion of natural killer cells controls persistent infection. J.Virol. 2014, 88:1953-1960.
60. Wherry E.J. T cell exhaustion. Nat. Immunol. 2011, 12:492-499.